Table 2.
With Dementia |
CIND |
Normal |
||||
---|---|---|---|---|---|---|
Adjusted Mean | 95% CI | Adjusted Mean | 95% CI | Adjusted Mean | 95% CI | |
Inflammation | ||||||
Albumin | 3.91* | 3.90, 3.92 | 3.94* | 3.93, 3.94 | 3.97 | 3.97, 3.97 |
CRP (log) | 0.82* | 0.82, 0.83 | 0.83* | 0.83, 0.83 | 0.84 | 0.84, 0.84 |
Neutrophil Lymphocyte Ratio (NLR) | 2.46* | 2.42, 2.50 | 2.38* | 2.37, 2.40 | 2.27 | 2.26, 2.27 |
Num of High-Risk z scored Cytokine Quartiles | 1.55* | 1.50, 1.60 | 1.43* | 1.40, 1.45 | 1.26 | 1.25, 1.26 |
IL6 Risk Quartile | 0.30* | 0.30, 0.31 | 0.28* | 0.28, 0.29 | 0.25 | 0.25, 0.25 |
IL10 Risk Quartile | 0.30* | 0.29, 0.31 | 0.28* | 0.28, 0.28 | 0.25 | 0.25, 0.25 |
IL-1Ra Risk Quartile | 0.24* | 0.24, 0.24 | 0.24* | 0.24, 0.24 | 0.25 | 0.25, 0.25 |
TGFβ1 Risk Quartile | 0.33* | 0.32, 0.34 | 0.30* | 0.29, 0.30 | 0.25 | 0.25, 0.25 |
TNFR1 Risk Quartile | 0.38* | 0.36, 0.40 | 0.33* | 0.32, 0.33 | 0.25 | 0.25, 0.26 |
Immune Functioning | ||||||
CMV Seronegative and Borderline | 10.61%* | 4.94, 16.29 | 23.11%* | 19.67, 26.55 | 39.96% | 38.17, 41.75 |
CMV Seropositive 1st Tertile | 30.10%* | 22.56, 37.65 | 26.11% | 22.67, 29.55 | 20.07% | 18.65, 21.49 |
CMV Seropositive 2nd Tertile | 27.84% | 20.77, 34.91 | 23.29% | 19.97, 26.61 | 20.80% | 19.34, 22.26 |
CMV Seropositive 3rd Tertile | 31.44%* | 23.73, 39.14 | 27.49%* | 23.91, 31.06 | 19.17% | 17.73, 20.61 |
CD4+ TN/TM | 0.99 | 0.98, 1.00 | 0.98 | 0.98, 0.99 | 0.98 | 0.98, 0.98 |
CD8+ TN/TM | 0.27* | 0.26, 0.29 | 0.31* | 0.30, 0.32 | 0.36 | 0.36, 0.37 |
*p < .05 indicates difference from normal dementia status.